BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol 2014; 20(26): 8351-8363 [PMID: 25024594 DOI: 10.3748/wjg.v20.i26.8351]
URL: https://www.wjgnet.com/1948-5182/full/v20/i26/8351.htm
Number Citing Articles
1
Alison J. Dawson, Eric S. Kilpatrick, Anne-Marie Coady, Abeer M. M. Elshewehy, Youssra Dakroury, Lina Ahmed, Stephen L. Atkin, Thozhukat Sathyapalan. Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight lossBMC Endocrine Disorders 2017; 17(1) doi: 10.1186/s12902-017-0194-2
2
Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak. The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort StudyHepatology 2021; 74(6): 2988 doi: 10.1002/hep.32034
3
Giselle Adriana Abruzzese, María Florencia Heber, María José Ferrer, Silvana Rocío Ferreira, Aimé Florencia Silva, Alicia Beatriz Motta. Effects of in utero androgen excess and metformin treatment on hepatic functionsMolecular and Cellular Endocrinology 2019; 491: 110416 doi: 10.1016/j.mce.2019.03.006
4
Amna Subhan Butt, Jalpa Devi. Polycystic Ovary Syndrome2024; : 92 doi: 10.1016/B978-0-323-87932-3.00021-9
5
Qingling Wang, Da Zhou, Mingjie Wang, Mingyu Zhu, Peizhan Chen, Hu Li, Meng Lu, Xinxin Zhang, Xizhong Shen, Taotao Liu, Li Chen. A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic PopulationFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.900794
6
Gashaw Abebe, Daniel Ayanaw, Tiget Ayelgn Mengstie, Gashaw Dessie, Tabarak Malik. Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast EthiopiaSAGE Open Medicine 2022; 10: 205031212211247 doi: 10.1177/20503121221124762
7
Nikolaos Nikolaou, Leanne Hodson, Jeremy W. Tomlinson. The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studiesThe Journal of Steroid Biochemistry and Molecular Biology 2021; 207: 105808 doi: 10.1016/j.jsbmb.2021.105808
8
Emily L. Zumbro, Manisha Rao, Shenavia Balcom-Luker, K. Shane Broughton, Monique J. LeMieux. Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)Nutrients 2021; 13(7): 2451 doi: 10.3390/nu13072451
9
Maja Milanović, Nataša Milošević, Jan Sudji, Stefan Stojanoski, Milica Atanacković Krstonošić, Artur Bjelica, Nataša Milić, Milica Medić Stojanoska. Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome?Clinica Chimica Acta 2020; 507: 257 doi: 10.1016/j.cca.2020.05.009
10
Gulnara Novbatova, Kelsey Timme, Andrew Severin, Maryam Sayadi, Aileen F Keating. Maternal pre-conceptional glyphosate exposure impacts the offspring hepatic and ovarian proteomeToxicological Sciences 2023; 194(1): 23 doi: 10.1093/toxsci/kfad047
11
Masataka Seike. The Liver in Systemic Diseases2016; : 251 doi: 10.1007/978-4-431-55790-6_12
12
Vasiliki Venetsanaki, Stergios A. Polyzos. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic PerspectivesCurrent Vascular Pharmacology 2019; 17(6): 546 doi: 10.2174/1570161116666180711121949
13
Oyekoya T Ayonrinde, Leon A Adams, Dorota A Doherty, Trevor A Mori, Lawrence J Beilin, Wendy H Oddy, Martha Hickey, Deborah M Sloboda, John K Olynyk, Roger Hart. Adverse metabolic phenotype of adolescent girls with non‐alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boysJournal of Gastroenterology and Hepatology 2016; 31(5): 980 doi: 10.1111/jgh.13241
14
Krisztina Lajtai, Csilla Terézia Nagy, Róbert Tarszabó, Rita Benkő, Leila Hadjadj, Réka Eszter Sziva, Dóra Gerszi, Bálint Bányai, Péter Ferdinandy, György László Nádasy, Zoltán Giricz, Eszter Mária Horváth, Szabolcs Várbíró. Effects of Vitamin D Deficiency on Proliferation and Autophagy of Ovarian and Liver Tissues in a Rat Model of Polycystic Ovary SyndromeBiomolecules 2019; 9(9): 471 doi: 10.3390/biom9090471
15
Myeong Jun Song, Jong Young Choi. Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulinFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1053709
16
Yong Chen, Leikai Ma, Zhouling Ge, Yizhao Pan, Lubin Xie. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary SyndromeFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.888194
17
Dong Liu, Xue Gao, Xiong-Fei Pan, Tao Zhou, Cairong Zhu, Fei Li, Jian-Gao Fan, Giovanni Targher, Jian Zhao. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndromeBMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-02775-0
18
Asieh Mansour, Maryam Mirahmad, Mohammad Reza Mohajeri-Tehrani, Mahdieh Jamalizadeh, Sedigheh Hosseinimousa, Fatemeh Rashidi, Pooria Asili, Sayed Mahmoud Sajjadi-Jazi. Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian populationScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-37513-2
19
Yasha V. Kameshwar, Gayatri Mishra. Inadvertent surgical bleeding in PCOS patient with splenomegaly and its association with Non Alcoholic Fatty Liver Disease (NAFLD)Journal of Anaesthesiology Clinical Pharmacology 2023; 39(4): 671 doi: 10.4103/joacp.joacp_188_22
20
Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan, Branka Filipović. Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical ImplicationsCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6678142
21
Alekya Devi Anala, Insiya Sajjad Hussain Saifudeen, Maryam Ibrahim, Moksha Nanda, Nida Naaz, Stephen L. Atkin. The Potential Utility of Tirzepatide for the Management of Polycystic Ovary SyndromeJournal of Clinical Medicine 2023; 12(14): 4575 doi: 10.3390/jcm12144575
22
Elizabeth M. Brunt, Vincent W.-S. Wong, Valerio Nobili, Christopher P. Day, Silvia Sookoian, Jacquelyn J. Maher, Elisabetta Bugianesi, Claude B. Sirlin, Brent A. Neuschwander-Tetri, Mary E. Rinella. Nonalcoholic fatty liver diseaseNature Reviews Disease Primers 2015; 1(1) doi: 10.1038/nrdp.2015.80
23
Maryan G Rizk, Varykina G Thackray. Intersection of Polycystic Ovary Syndrome and the Gut MicrobiomeJournal of the Endocrine Society 2021; 5(2) doi: 10.1210/jendso/bvaa177
24
Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter. Sex‐specific aspects of venous thromboembolism: What is new and what is next?Research and Practice in Thrombosis and Haemostasis 2022; 6(4): e12722 doi: 10.1002/rth2.12722
25
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Extrahepatic complications of non-alcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(4): 472 doi: 10.1016/j.rgmxen.2019.05.004
26
Ioannis G. Lempesis, Samuel J. Apple, Gustavo Duarte, Leonidas Palaiodimos, Dimitrios Rafail Kalaitzopoulos, Maria Dalamaga, Damianos G. Kokkinidis. Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndromeDiabetes/Metabolism Research and Reviews 2023; 39(6) doi: 10.1002/dmrr.3682
27
Dagmar Ehling. Anticipation and Medicine2017; : 293 doi: 10.1007/978-3-319-45142-8_18
28
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic DiseasesEndocrinology 2020; : 1 doi: 10.1007/978-3-319-66362-3_6-1
29
Evangeline Vassilatou, Sophia Lafoyianni, Dimitra Argyro Vassiliadi, Dimitrios Ioannidis, Stavroula A. Paschou, Maria Mizamtsidi, Maria Panagou, Andromachi Vryonidou. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndromeMaturitas 2018; 116: 1 doi: 10.1016/j.maturitas.2018.06.013
30
Imaobong Inyang, Hunter E. White, Kelsey Timme, Aileen F. Keating. Biological sex differences in hepatic response to in utero dimethylbenz(a)anthracene exposureReproductive Toxicology 2024; 124: 108553 doi: 10.1016/j.reprotox.2024.108553
31
Muhammad Sohaib Khan, Hee-Sun Kim, Ranhee Kim, Sang Ho Yoon, Sang Geon Kim. Dysregulated Liver Metabolism and Polycystic Ovarian SyndromeInternational Journal of Molecular Sciences 2023; 24(8): 7454 doi: 10.3390/ijms24087454
32
Stavroula A. Paschou, Stergios A. Polyzos, Panagiotis Anagnostis, Dimitrios G. Goulis, Christina Kanaka-Gantenbein, Irene Lambrinoudaki, Neoklis A. Georgopoulos, Andromachi Vryonidou. Nonalcoholic fatty liver disease in women with polycystic ovary syndromeEndocrine 2020; 67(1): 1 doi: 10.1007/s12020-019-02085-7
33
Maria Victoria Bazzano, Angela Köninger, Maria Emilia Solano. Immunologische Veränderungen beim Syndrom polyzystischer OvarienGynäkologische Endokrinologie 2023; 21(4): 231 doi: 10.1007/s10304-023-00532-3
34
Łukasz Blukacz, Artur Nowak, Mariusz Wójtowicz, Angelika Krawczyk, Grzegorz Franik, Paweł Madej, Dagmara Pluta, Karolina Kowalczyk, Michał Żorniak. Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ SequenceBiomedicines 2022; 10(9): 2193 doi: 10.3390/biomedicines10092193
35
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual DysfunctionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
36
Sambit Roy, Aierken Abudu, Irving Salinas, Niharika Sinha, Holly Cline-Fedewa, Alexandra M Yaw, Wenjie Qi, Todd A Lydic, Diana L Takahashi, Jon D Hennebold, Hanne M Hoffmann, Jianrong Wang, Aritro Sen. Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS MiceEndocrinology 2022; 163(10) doi: 10.1210/endocr/bqac127
37
Georgios S. Papaetis, Panagiota K. Filippou, Kiriaki G. Constantinidou, Christina S. Stylianou. Liraglutide: New Perspectives for the Treatment of Polycystic Ovary SyndromeClinical Drug Investigation 2020; 40(8): 695 doi: 10.1007/s40261-020-00942-2
38
Danalea V Skarra, Angelina Hernández-Carretero, Alissa J Rivera, Arya R Anvar, Varykina G Thackray. Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin ResistanceEndocrinology 2017; 158(9): 2988 doi: 10.1210/en.2016-1898
39
Sai-Hua Zheng, Xue-Lian Li. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOSGynecological Endocrinology 2016; 32(3): 177 doi: 10.3109/09513590.2015.1111327
40
Joon-yeon Kim, Tae-uk Wang, Jong-bong Kim, Byung-cheon Kweon, Kyeong-moog Kim, Jong-ho Lee. Availability of the Fatty-Liver-Disease Quantification Technique Using MRI : Comparison of Screening Dixon, Multi Echo Dixon, HISTO, and UltrasonographyJournal of the Korean Society of MR Technology 2017; 27(1): 13 doi: 10.31159/ksmrt.2017.27.1.13
41
Mohamed Shengir, Srinivasan Krishnamurthy, Peter Ghali, Marc Deschenes, Philip Wong, Tianyan Chen, Giada Sebastiani. Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndromeWorld Journal of Gastroenterology 2020; 26(44): 7046-7060 doi: 10.3748/wjg.v26.i44.7046
42
Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Korale Gedara Dayaratne, Farika Nirmani De Silva, Jagath Keerthi Premadasa, Suneth Buddhika Agampodi. Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)BMJ Open Gastroenterology 2022; 9(1): e000831 doi: 10.1136/bmjgast-2021-000831
43
Mohammad Maysara Asfari, Muhammad Talal Sarmini, Firas Baidoun, Yasser Al-Khadra, Yamen Ezzaizi, Srinivasan Dasarathy, Arthur McCullough. Association of non-alcoholic fatty liver disease and polycystic ovarian syndromeBMJ Open Gastroenterology 2020; 7(1): e000352 doi: 10.1136/bmjgast-2019-000352
44
Tsung-Sheng Chen, Yi-Ting Chen, Chia-Hsin Liu, Chi-Ching Sun, Frank Chiahung Mao. Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOSGynecological Endocrinology 2017; 33(1): 48 doi: 10.1080/09513590.2016.1205579
45
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitisWorld Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
46
Erdinc Gulumsek, Burcak Cakir Pekoz, Ayse Selcan Koc, Muhammed Zubeyir Aslan, Huseyin Ali Ozturk, Fatih Necip Arici, Hilmi Erdem Sumbul. Liver Stiffness Is Increased in Polycystic Ovary Syndrome and Related With Complement C1q/Tumor Necrosis Factor–Related Protein 3 LevelsUltrasound Quarterly 2021; 37(2): 133 doi: 10.1097/RUQ.0000000000000537
47
Mahrukh Shahbaz, Halah Almatooq, Paul Foucambert, Faith D Esbrand, Sana Zafar, Venkatesh Panthangi, Adrienne R Cyril Kurupp, Anjumol Raju, Gaurav Luthra, Safeera Khan. A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeCureus 2022;  doi: 10.7759/cureus.29928
48
Christian S. Göbl, Johannes Ott, Latife Bozkurt, Michael Feichtinger, Victoria Rehmann, Anna Cserjan, Maike Heinisch, Helmut Steinbrecher, Ivica JustKukurova, Radka Tuskova, Michael Leutner, Elisabeth Vytiska-Binstorfer, Christine Kurz, Andrea Weghofer, Andrea Tura, Christian Egarter, Alexandra Kautzky-Willer, Andrew Wolfe. To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOSPLOS ONE 2016; 11(8): e0160571 doi: 10.1371/journal.pone.0160571
49
R. A. Condorelli, A. E. Calogero, M. Di Mauro, L. M. Mongioi’, R. Cannarella, G. Rosta, S. La Vignera. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass indexJournal of Endocrinological Investigation 2018; 41(4): 383 doi: 10.1007/s40618-017-0762-3
50
Paulina Vidal-Cevallos, Alejandra Mijangos-Trejo, Misael Uribe, Norberto Chávez Tapia. The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary SyndromeEndocrinology and Metabolism Clinics of North America 2023; 52(3): 533 doi: 10.1016/j.ecl.2023.01.005
51
Natalia Zeber-Lubecka, Maria Kulecka, Katarzyna Suchta, Michalina Dąbrowska, Michał Ciebiera, Ewa E. Hennig. Association of Mitochondrial Variants with the Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s ThyroiditisAntioxidants 2023; 12(11): 1983 doi: 10.3390/antiox12111983
52
Amarjeet Singh, Shalini Gainder, Pradipta Banerjee, Apurva Goel, Pawan Kumar, Banashree Mondal, Samudra P. Banik, Debasis Bagchi. Efficacy of a Proprietary Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): a Randomized, Double-Blind, Placebo-Controlled StudyJournal of the American Nutrition Association 2023; 42(7): 651 doi: 10.1080/27697061.2022.2126410
53
Komei Iwai, Tetsuji Azuma, Takatoshi Yonenaga, Yasuyuki Sasai, Kazutoshi Watanabe, Fumiko Deguchi, Akihiro Obora, Takao Kojima, Takaaki Tomofuji. Relationship between Chewing Status and Fatty Liver Diagnosed by Liver/Spleen Attenuation Ratio: A Cross-Sectional StudyInternational Journal of Environmental Research and Public Health 2022; 20(1): 307 doi: 10.3390/ijerph20010307
54
Binghan Jin, Zhaoyuan Wu, Shan Wang, Zhu Yu, Rahim Ullah, Xinyi Liang, Wei Wu, Ke Huang, Yan Ni, Jianbing Wang, Guanping Dong, Junfen Fu. Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional studyHepatology International 2024; 18(1): 179 doi: 10.1007/s12072-023-10596-9
55
Phiwayinkosi V. Dludla, Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, Tawanda M. Nyambuya, Fabio Marcheggiani, Ilenia Cirilli, Khanyisani Ziqubu, Samukelisiwe C. Shabalala, Rabia Johnson, Johan Louw, Elisabetta Damiani, Luca Tiano. N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the LiteratureAntioxidants 2020; 9(12): 1283 doi: 10.3390/antiox9121283
56
Adjoa Osei-Ntansah, Trinitee Oliver, Taylor Lofton, Claire Falzarano, Kiana Carr, Ruthe Huang, Andre Wilson, Ella Damaser, Guyton Harvey, Md Ahasanur Rahman, Stanley Andrisse. Liver Androgen Receptor Knockout Improved High-fat Diet Induced Glucose Dysregulation in Female Mice But Not Male MiceJournal of the Endocrine Society 2024; 8(4) doi: 10.1210/jendso/bvae021
57
Giselle Adriana Abruzzese, Maria Florencia Heber, Silvana Rocio Ferreira, Leandro Martin Velez, Roxana Reynoso, Omar Pedro Pignataro, Alicia Beatriz Motta. Prenatal hyperandrogenism induces alterations that affect liver lipid metabolismJournal of Endocrinology 2016; 230(1): 67 doi: 10.1530/JOE-15-0471
58
HafejaAkhter Hima, MdAbdul Hannan Miah, NipaRani Ghosh, Sazia Sultana, Tanjina Akter, FatemaTuz Zahura Aalpona, AB. M. Kamrul-Hasan. Nonalcoholic fatty liver disease in polycystic ovary syndrome: Result of a single-center cross-sectional study in BangladeshBangladesh Journal of Endocrinology and Metabolism 2023; 2(2): 80 doi: 10.4103/bjem.bjem_10_23
59
Marzieh Saei Ghare Naz, Vida Ghasemi, Shabahang Amirshekari, Fahimeh Ramezani Tehrani. Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?Endocrinology, Diabetes & Metabolism 2024; 7(2) doi: 10.1002/edm2.477
60
Yuying Wang, Xiaojing Guo, Wendi Xu, Jie Cai, Yi Zhang, Chunhua Wu, Shengxian Li, Yun Sun, Wei Liu, Tao Tao. Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous?Endocrine Practice 2020; 26(9): 1003 doi: 10.4158/EP-2019-0407
61
Peng Cui, Wei Hu, Tong Ma, Min Hu, Xiaoyu Tong, Feifei Zhang, Jiemei Shi, Xiaoqing Xu, Xin Li, Linus Ruijin Shao, Håkan Billig, Yi Feng. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like ratsThe Journal of Steroid Biochemistry and Molecular Biology 2021; 208: 105829 doi: 10.1016/j.jsbmb.2021.105829
62
Natalia Zeber-Lubecka, Michał Ciebiera, Ewa E. Hennig. Polycystic Ovary Syndrome and Oxidative Stress—From Bench to BedsideInternational Journal of Molecular Sciences 2023; 24(18): 14126 doi: 10.3390/ijms241814126
63
Hassan Malekinejad, Shima Zeynali-Moghaddam, Ali Rezaei-Golmisheh, Aylar Alenabi, Faezeh Malekinejad, Arash Alizadeh, Vahid Shafie-Irannejad. Lupeol attenuated the NAFLD and PCOS-induced metabolic, oxidative, hormonal, histopathological, and molecular injuries in miceResearch in Pharmaceutical Sciences 2023; 18(5): 551 doi: 10.4103/1735-5362.383710
64
Saqib Hassan, Marika A. Kaakinen, Harmen Draisma, Liudmila Zudina, Mohd A. Ganie, Aafia Rashid, Zhanna Balkhiyarova, George S. Kiran, Paris Vogazianos, Christos Shammas, Joseph Selvin, Athos Antoniades, Ayse Demirkan, Inga Prokopenko. Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary SyndromeGenes 2022; 13(2): 379 doi: 10.3390/genes13020379
65
F. Coperchini, P. Leporati, M. Rotondi, L. Chiovato. Expanding the therapeutic spectrum of metformin: from diabetes to cancerJournal of Endocrinological Investigation 2015; 38(10): 1047 doi: 10.1007/s40618-015-0370-z
66
Kristina R. Chacko, John Reinus. Extrahepatic Complications of Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2016; 20(2): 387 doi: 10.1016/j.cld.2015.10.004
67
Miguel Malespin, Ammar Nassri. Endocrine Diseases and the LiverClinics in Liver Disease 2019; 23(2): 233 doi: 10.1016/j.cld.2018.12.006
68
Shakeela Khalid, Muhammad Arshad, Komal Raza, Shahid Mahmood, Farzana Siddique, Nida Aziz, Sarfraz Khan, Waseem Khalid, Ammar AL‐Farga, Faisal Aqlan. Assessment of hepatoprotective, nephroprotective efficacy, and antioxidative potential of Moringa oleifera leaf powder and ethanolic extract against PCOS‐induced female albino mice (Mus Musculus)Food Science & Nutrition 2023; 11(11): 7206 doi: 10.1002/fsn3.3646
69
A. J. Krentz, K. Fujioka, M. Hompesch. Evolution of pharmacological obesity treatments: focus on adverse side‐effect profilesDiabetes, Obesity and Metabolism 2016; 18(6): 558 doi: 10.1111/dom.12657
70
Tianhe Li, Tingting Zhang, Tianyu Cui, Yuxi Yang, Ruixia Liu, Yi Chen, Chenghong Yin. Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndromeThe Journal of Steroid Biochemistry and Molecular Biology 2020; 204: 105752 doi: 10.1016/j.jsbmb.2020.105752
71
Kelly N Z Fuller, Julie Allen, Roshan Kumari, Jephte Y Akakpo, Meghan Ruebel, Kartik Shankar, John P Thyfault. Pre– and Post–Sexual Maturity Liver-specific ERα Knockout Does Not Impact Hepatic Mitochondrial FunctionJournal of the Endocrine Society 2023; 7(6) doi: 10.1210/jendso/bvad053
72
Pushplata Sankhwar, S. P. Jaiswar, Sonali Yadav, Vandana Awasthi, Apurva Goel, Pawan Kumar, Samudra P. Banik, Manashi Bagchi, Debasis Bagchi. Beneficial Effects of a Novel Fenugreek Seed Extract (Trigonella foenum-graecum, Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): A Follow-up Compliance Clinical InvestigationJournal of the American Nutrition Association 2023; 42(7): 691 doi: 10.1080/27697061.2022.2145526
73
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care providerPostgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
74
ShanHu Gao, Fei Long, Zheng Jiang, Jun Shi, DongXue Ma, Yang Yang, Jin Bai, Ting-Li Han. The complex metabolic interactions of liver tissue and hepatic exosome in PCOS mice at young and middle ageFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.990987
75
Nasser Alorfi, Ahmed Ashour. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov RegistryDiabetes, Metabolic Syndrome and Obesity 2023; : 3115 doi: 10.2147/DMSO.S430740
76
Ishfaq Hassan Mir, Saqib Hassan, Joseph Selvin, Chinnasamy Thirunavukkarasu. Human Microbiome in Health, Disease, and Therapy2023; : 127 doi: 10.1007/978-981-99-5114-7_7
77
Fan Hong, Pengfei Xu, Yonggong Zhai. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and DevelopmentInternational Journal of Molecular Sciences 2018; 19(8): 2189 doi: 10.3390/ijms19082189
78
Fahimeh Shams, Monireh Aghajani-nasab, Mahsa Ramezanpour, Razieh Habibipour Fatideh, Fahimeh Mohammadghasemi. Effect of apple vinegar on folliculogenesis and ovarian kisspeptin in a high-fat diet-induced nonalcoholic fatty liver disease in ratBMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01205-1
79
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim. Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver diseaseClinical and Molecular Hepatology 2021; 27(2): 221 doi: 10.3350/cmh.2020.0239
80
Aimé Florencia Silva, Giselle Adriana Abruzzese, María José Ferrer, María Florencia Heber, Silvana Rocío Ferreira, Gloria Edith Cerrone, Alicia Beatriz Motta. Fetal programming by androgen excess impairs liver lipid content and PPARg expression in adult ratsJournal of Developmental Origins of Health and Disease 2022; 13(3): 300 doi: 10.1017/S2040174421000416
81
Yi Tan, Xing Liang Jin, Weiguo Lao, Jane Kim, Linda Xiao, Xianqin Qu. Antiresistin RNA Oligonucleotide Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Attenuating Proinflammatory CytokinesBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/414860
82
Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndromeIndian Journal of Medical Research 2020; 151(4): 333 doi: 10.4103/ijmr.IJMR_610_18
83
Abhaya Krishnan, Sridhar Muthusami, Loganayaki Periyasamy, Jone A. Stanley, Vasudevan Gopalakrishnan, Ilangovan Ramachandran. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary MorphologyMedicina 2020; 56(3): 100 doi: 10.3390/medicina56030100
84
Unaiza Qamar, Stephen L. Atkin, Thozhukat Sathyapalan. Practical Guide to Obesity Medicine2018; : 59 doi: 10.1016/B978-0-323-48559-3.00006-3
85
E Vassilatou, D A Vassiliadi, K Salambasis, H Lazaridou, N Koutsomitopoulos, N Kelekis, D Kassanos, D Hadjidakis, G Dimitriadis. Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver diseaseEuropean Journal of Endocrinology 2015; 173(6): 739 doi: 10.1530/EJE-15-0567
86
Timothy Wang, Wei Yang, Sidika Karakas, Souvik Sarkar. NASH in Nondiabetic Endocrine DisordersMetabolic Syndrome and Related Disorders 2018; 16(7): 315 doi: 10.1089/met.2018.0044
87
Muraly Puttabyatappa, Vasantha Padmanabhan. Ovarian and extra-ovarian mediators in the development of polycystic ovary syndromeJournal of Molecular Endocrinology 2018; 61(4): R161 doi: 10.1530/JME-18-0079
88
Richie Manikat, Mindie H. Nguyen. Nonalcoholic fatty liver disease and non-liver comorbiditiesClinical and Molecular Hepatology 2023; 29(Suppl): s86 doi: 10.3350/cmh.2022.0442
89
Rosita A. Condorelli, Aldo E. Calogero, Maurizio Di Mauro, Sandro La Vignera. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolutionGynecological Endocrinology 2017; 33(9): 665 doi: 10.1080/09513590.2017.1342240
90
Rui Han, Xiaoyun Gong, Yuejie Zhu, Xiaoran Liu, Yan Xia, Yuhong Huang, Meng Zhang, Yunian Zhang, Xiaolin La, Jianbing Ding, Silvia Gregori. Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary SyndromeBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9596358
91
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormonesFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
92
Giuliana Motta, Soundara Viveka Thangaraj, Vasantha Padmanabhan. Developmental Programming: Impact of Prenatal Exposure to Bisphenol A on Senescence and Circadian Mediators in the Liver of SheepToxics 2023; 12(1): 15 doi: 10.3390/toxics12010015
93
Stanley Andrisse, Mingxiao Feng, Zhiqiang Wang, Olubusayo Awe, Lexiang Yu, Haiying Zhang, Sheng Bi, Hongbing Wang, Linhao Li, Serene Joseph, Nicola Heller, Franck Mauvais‐Jarvis, Guang William Wong, James Segars, Andrew Wolfe, Sara Divall, Rexford Ahima, Sheng Wu. Androgen‐induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in femalesThe FASEB Journal 2021; 35(10) doi: 10.1096/fj.202100961R
94
Monika Sarkar, Melissa Wellons, Marcelle I Cedars, Lisa VanWagner, Erica P Gunderson, Veeral Ajmera, Laura Torchen, David Siscovick, Jeffrey J Carr, James G Terry, Mary Rinella, Cora E Lewis, Norah Terrault. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in MidlifeAmerican Journal of Gastroenterology 2017; 112(5): 755 doi: 10.1038/ajg.2017.44
95
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, Tom Houben. Prevention and Treatment of AtherosclerosisHandbook of Experimental Pharmacology 2020; 270: 233 doi: 10.1007/164_2020_352
96
Agata Łukawska, Marcin Kałużny, Sonia Nogalska, Eliza Kubicka, Justyna Kuliczkowska-Płaksej, Marek Bolanowski. Polycystic ovary syndrome and non-alcoholic fatty liver disease: Matched pair or sporadic coexistence?Postępy Higieny i Medycyny Doświadczalnej 2020; 74: 377 doi: 10.5604/01.3001.0014.3920
97
Yvonne M. Jeanes, Sue Reeves. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challengesNutrition Research Reviews 2017; 30(1): 97 doi: 10.1017/S0954422416000287
98
Shikha Rani, Piyush Chandna. Multiomics Analysis–Based Biomarkers in Diagnosis of Polycystic Ovary SyndromeReproductive Sciences 2023; 30(1): 1 doi: 10.1007/s43032-022-00863-9
99
Nazia Begum, Kandavalli Manipriya, B. Veeresh. Role of high-fat diet on letrozole-induced polycystic ovarian syndrome in ratsEuropean Journal of Pharmacology 2022; 917: 174746 doi: 10.1016/j.ejphar.2022.174746
100
Annie Chen, Alex Handzel, Lillian Sau, Laura Cui, Scott T. Kelley, Varykina G. Thackray. Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female miceEndocrinology, Diabetes & Metabolism 2024; 7(1) doi: 10.1002/edm2.443
101
J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, K.R. García-Zermeño, E.C. Morel-Cerda, J.M. Aldana-Ledesma, G.E. Castro-Narro, S. Cerpa-Cruz, D.K. Tapia-Calderón, L.A. Mercado-Jauregui, R. Contreras-Omaña. Complicaciones extrahepáticas de la enfermedad por hígado graso no alcohólico: impacto más allá del hígadoRevista de Gastroenterología de México 2019; 84(4): 472 doi: 10.1016/j.rgmx.2019.05.004
102
Linlin Fu, Yexing Li, Yuehong Bian, Qiumin Wang, Jingyu Li, Ying Wang, Tiantian Zhang, Xiaoyan Zou, Linlin Cui, Zijiang Chen. The Nutritional Intervention Improves the Metabolic Profile of Overweight and Obese PCOS Along with the Differences in Gut MicrobiotaReproductive Sciences 2023; 30(7): 2210 doi: 10.1007/s43032-022-01131-6
103
Diego A. Miranda, William C. Krause, Amaury Cazenave-Gassiot, Miyuki Suzawa, Hazel Escusa, Juat Chin Foo, Diyala S. Shihadih, Andreas Stahl, Mark Fitch, Edna Nyangau, Marc Hellerstein, Markus R. Wenk, David L. Silver, Holly A. Ingraham. LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversityJCI Insight 2018; 3(5) doi: 10.1172/jci.insight.96151
104
Yoseph Asmelash Gebru, Haripriya Gupta, Hyeong Seop Kim, Jung A. Eom, Goo Hyun Kwon, Eunju Park, Jin-Ju Jeong, Sung-Min Won, Satya Priya Sharma, Raja Ganesan, Dong Joon Kim, Ki Tae Suk. T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(22): 12190 doi: 10.3390/ijms222212190
105
Dariusz Szukiewicz, Seweryn Trojanowski, Anna Kociszewska, Grzegorz Szewczyk. Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic FactorsInternational Journal of Molecular Sciences 2022; 23(23): 14663 doi: 10.3390/ijms232314663
106
Peng Cui, Jie-Mei Shi, Tong Ma, Lin Rao, Xiao-Yu Tong, Wei Hu, Xiao-Qing Xu, Fei-Fei Zhang, Xin Li, Håkan Billig, Linus R. Shao, Yi Feng. Long-Term Androgen-Induced Nonalcoholic Fatty Liver Disease in a Polycystic Ovary Syndrome Mouse Model is Related to Mitochondrial DysfunctionReproductive and Developmental Medicine 2021; 5(2): 71 doi: 10.4103/2096-2924.320884
107
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic DiseasesEndocrinology 2021; : 157 doi: 10.1007/978-3-319-68729-2_6
108
Ana Maria Singeap, Laura Huiban. Essentials of Non-Alcoholic Fatty Liver Disease2023; : 183 doi: 10.1007/978-3-031-33548-8_16
109
Varykina G. Thackray. Sex, Microbes, and Polycystic Ovary SyndromeTrends in Endocrinology & Metabolism 2019; 30(1): 54 doi: 10.1016/j.tem.2018.11.001
110
Suliman Al Humayed. Protective and therapeutic effects ofCrataegus aroniain non-alcoholic fatty liver diseaseArchives of Physiology and Biochemistry 2017; 123(1): 23 doi: 10.1080/13813455.2016.1205097
111
Shih-Yi Lin, Yu-Cih Yang, Cherry Yin-Yi Chang, Cheng-Chieh Lin, Wu-Huei Hsu, Shu-Woei Ju, Chung-Y. Hsu, Chia-Hung Kao. Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort AnalysisInternational Journal of Environmental Research and Public Health 2019; 16(23): 4816 doi: 10.3390/ijerph16234816